Cleararc Capital Inc. lowered its holdings in CME Group Inc (NASDAQ:CME) by 1.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,623 shares of the financial services provider’s stock after selling 407 shares during the quarter. Cleararc Capital Inc.’s holdings in CME Group were worth $4,702,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of the business. LPL Financial LLC raised its holdings in shares of CME Group by 9.2% in the 3rd quarter. LPL Financial LLC now owns 22,500 shares of the financial services provider’s stock valued at $3,830,000 after buying an additional 1,897 shares during the period. Lido Advisors LLC raised its holdings in shares of CME Group by 18.7% in the 3rd quarter. Lido Advisors LLC now owns 2,546 shares of the financial services provider’s stock valued at $433,000 after buying an additional 401 shares during the period. Utah Retirement Systems raised its holdings in shares of CME Group by 0.5% in the 3rd quarter. Utah Retirement Systems now owns 63,200 shares of the financial services provider’s stock valued at $10,757,000 after buying an additional 300 shares during the period. First Republic Investment Management Inc. raised its holdings in shares of CME Group by 35.4% in the 3rd quarter. First Republic Investment Management Inc. now owns 96,791 shares of the financial services provider’s stock valued at $16,475,000 after buying an additional 25,307 shares during the period. Finally, Tiverton Asset Management LLC raised its holdings in shares of CME Group by 78.0% in the 3rd quarter. Tiverton Asset Management LLC now owns 61,960 shares of the financial services provider’s stock valued at $10,546,000 after buying an additional 27,152 shares during the period. Institutional investors own 85.89% of the company’s stock.
Several research firms recently issued reports on CME. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a report on Tuesday, September 18th. Citigroup started coverage on CME Group in a research note on Tuesday, November 20th. They set a “buy” rating and a $220.00 target price for the company. Atlantic Securities started coverage on CME Group in a research note on Wednesday, November 28th. They set a “neutral” rating and a $200.00 target price for the company. Bank of America reissued a “buy” rating and set a $200.00 target price on shares of CME Group in a research note on Monday, November 5th. Finally, Deutsche Bank boosted their target price on CME Group from $205.00 to $206.00 and gave the stock a “buy” rating in a research note on Friday, November 16th. Six analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $194.13.
In other news, insider Julie Winkler sold 5,847 shares of the company’s stock in a transaction dated Friday, November 16th. The stock was sold at an average price of $195.01, for a total transaction of $1,140,223.47. Following the completion of the transaction, the insider now directly owns 24,255 shares of the company’s stock, valued at approximately $4,729,967.55. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Charles P. Carey sold 2,800 shares of the company’s stock in a transaction dated Friday, November 2nd. The stock was sold at an average price of $183.45, for a total value of $513,660.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 29,800 shares of company stock valued at $5,628,462. Insiders own 0.43% of the company’s stock.
CME opened at $189.02 on Friday. CME Group Inc has a 12 month low of $143.68 and a 12 month high of $197.08. The firm has a market cap of $63.96 billion, a P/E ratio of 39.63, a P/E/G ratio of 2.19 and a beta of 0.46. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.15.
CME Group (NASDAQ:CME) last released its earnings results on Thursday, October 25th. The financial services provider reported $1.45 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.42 by $0.03. The firm had revenue of $904.20 million during the quarter, compared to analysts’ expectations of $910.50 million. CME Group had a return on equity of 9.18% and a net margin of 113.67%. As a group, research analysts forecast that CME Group Inc will post 6.65 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 27th. Stockholders of record on Monday, December 10th will be given a dividend of $0.70 per share. The ex-dividend date is Friday, December 7th. This represents a $2.80 annualized dividend and a dividend yield of 1.48%. CME Group’s dividend payout ratio is currently 58.70%.
ILLEGAL ACTIVITY NOTICE: This report was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another site, it was stolen and republished in violation of United States & international copyright & trademark law. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/12/07/cme-group-inc-cme-shares-sold-by-cleararc-capital-inc.html.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Further Reading: How Do I Invest in Dividend Stocks
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.